Healthpeak Properties Inc.
DOC | NYSE
$19.03
+$0.09 (+0.45%)
At close: Oct 30, 2026, 4:00 PM ET
$19.37
+$0.34 (+1.79%)
Pre-market:
Nov 2, 2026, 6:07 AM ET
Market Data
Market Cap $13.12B
Enterprise Value $21.82B
Beta 0.99
Average Volume 5.69M
Shares Outstanding (Diluted) 689.89M
Shares Change YoY -1.04%
Institutional Ownership 97.48%
Exchange NYSE
ISIN US42250P1030
Price Performance
Price Change 1M -4.7%
Price Change 3M -12.8%
Price Change 6M 15.9%
Price Change YTD 18.4%
Price Change 1Y 6.0%
Price Change 3Y 22.4%
Price Change 5Y -46.4%
1M CAGR (ann.) -5.9%
1Y CAGR (ann.) 15.6%
5Y CAGR (ann.) -4.4%
All-Time CAGR 2.0%
Valuation
PE Ratio 54.37
Forward PE 85.43
PEG Ratio -0.12
Forward PEG 0.01
PS Ratio 4.45
Forward PS 4.20
PB Ratio 1.67
P/FCF Ratio 44.30
P/Adj. FCF Ratio 47.89
P/OCF Ratio 10.69
EV/Sales 7.40
EV/EBIT 31.84
EV/EBITDA 12.24
EV/FCF 73.65
Earnings Yield 1.8%
FCF Yield 2.3%
Adj. FCF Yield 2.1%
Financial Health
Net Debt $8.41B
Total Debt $10.32B
Cash & Short-Term Investments $1.63B
Total Assets $21.68B
Current Ratio 2.52
Quick Ratio 2.52
Debt / Equity Ratio 1.32
Debt / EBITDA 5.79
Debt / FCF 34.84
OCF / Debt 0.12
Interest Coverage 1.54
Altman Z-Score 0.95
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 2.5%
Operating Profit Margin 17.6%
EBITDA Margin 59.2%
Net Profit Margin 8.6%
FCF Margin 10.0%
Adj. FCF Margin 9.3%
SBC / Revenue 0.8%
SBC Impact (per share) -7.5%
Returns
Return on Assets 1.2%
Return on Equity 3.3%
Return on Invested Capital 16.1%
Return on Capital Employed 2.5%
Return on Tangible Assets 1.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 11.7%
Revenue CAGR 5Y 19.1%
Revenue CAGR 10Y 2.1%
EPS CAGR 3Y -28.8%
EPS CAGR 5Y -17.8%
EPS CAGR 10Y -13.2%
FCF CAGR 3Y -31.5%
FCF CAGR 5Y -18.0%
FCF CAGR 10Y -13.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 15
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y 8.6%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.06
EPS Growth Est (next Q) -137.4%
Revenue Est (next Q) $739.18M
Revenue Growth Est (next Q) 7.1%
Fair Value Estimates
Graham Number $10.41
Graham Upside -45.3%
Lynch Fair Value $1.75
Lynch Upside -90.8%
Price Target $22.00
Price Target Upside 15.6%
Cash Flow
Operating Cash Flow $1.23B
Free Cash Flow $296.21M
Adj. Free Cash Flow $273.98M
FCF Per Share $0.43
OCF Per Share $1.78
OCF/S Ratio 41.7%
Income Statement
Revenue $2.95B
Gross Profit $74.71M
Operating Income $519.46M
EBITDA $1.78B
Net Income $253.72M
EPS (Diluted) $0.35
Revenue / Employee $7.18M
Profit / Employee $617.32K
Employees 411
Dividends
Annual Dividend $1.22
Dividend Yield 6.41%
Payout Ratio 348.6%
FCF Payout Ratio 285.6%
Adj. FCF Payout Ratio 308.8%
Dividend Growth (YoY) -45.0%
Pay Frequency Monthly
Ex-Dividend Date Dec 18, 2026
Add to Watchlist
Select watchlists to add or remove DOC